...
首页> 外文期刊>Clinical and Translational Medicine >Identification of a novel miR‐21‐3p/TGF‐β signaling‐driven immune escape via the MHC class I/biglycan axis in tumor cells
【24h】

Identification of a novel miR‐21‐3p/TGF‐β signaling‐driven immune escape via the MHC class I/biglycan axis in tumor cells

机译:通过MHC IS / Biglycan轴在肿瘤细胞中鉴定新的MIR-21-3P / TGF-β信号驱动的免疫逸出

获取原文
           

摘要

For the first time, a miR-21-3p-mediated downregu- lation of MHC class I surface antigens was shown in different model systems, which is linked to the expression of the extracellular matrix (ECM) constituent biglycan (BGN) and transforming growth factor (TGF)-β signaling in HER-2/neu-positive (HER-2/neu + ) cells. HER-2/neu transformationinducestheexpressionofmiR-21-3p,which interferes with the expression of immune-modulatory molecules, thereby accelerating immune suppression and reducing tumor immunogenicity.
机译:首次,在不同的模型系统中示出了MIR-21-3P介导的MHC I型表面抗原的下调,其与细胞外基质(ECM)组分大学(BGN)的表达和转化生长的表达相关在Her-2 / Neu-阳性(HER-2 / Neu +)细胞中的因子(TGF)-β信号传导。 Her-2 / Neu转化inducestheexpressionofmir-21-3p,其干扰免疫调节分子的表达,从而加速免疫抑制和降低肿瘤免疫原性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号